Van der Meide P H, Duisterwinkel F J, De Graaf J M, Kraal B, Bosch L, Douglass J, Blumenthal T
Eur J Biochem. 1981 Jun;117(1):1-6. doi: 10.1111/j.1432-1033.1981.tb06294.x.
The molecular properties of two mutant species of the elongation factor Tu (EF-Tu), derived from either tuf A or tuf B, have been studied. One, designated EF-TuAR, is the product of a kirromycin-resistant tufA gene. The other designated EF-TuBO is a tuf B product and is present in a kirromycin-resistant mutant of Escherichia coli (LBE 2012) also harbouring the EF-TuAR species. EF-TuAR has been isolated in homogeneous form as a single gene product from the mutant strain LBE 2045, in which the tuf B gene has been inactivated by an insertion of the bacteriophage Mu. EF-TuBO has been isolated from LBE 2012 together with EF-TuAR in a 1:1 mixture. Fractionation of this mixture of DEAE-Sephadex A-50 resulted in an enrichment of EF-TuBO of about 80%. The properties of EF-TuAR and EF-TuBO have been compared to those of a kirromycin-sensitive species designated EF-TuAS, which was isolated from LBE 2045 by transduction of wild-type tuf A. We show here that all three EF-Tu species are fully competent to sustain polypeptide synthesis. All also appear to interact normally with guanine nucleotides and EF-Ts. Only in the presence of the antibiotic do the following differences appear. (a) Kirromycin causes EF-TuAS (wild-type tuf A gene product) to be retained on, and thus block, the ribosome. (b) EF-TuAR fails to bind the antibiotic and thus is capable of protein synthesis in its presence. (c) EF-TuBO fails to sustain polypeptide synthesis upon binding of kirromycin. It does not, however, block the ribosome, so the strain harbouring both this protein and EF-TuAR (LBE 2012) is kirromycin resistant.
对来源于tuf A或tuf B的延伸因子Tu(EF-Tu)的两种突变体的分子特性进行了研究。一种命名为EF-TuAR,是抗奇霉素tufA基因的产物。另一种命名为EF-TuBO,是tuf B的产物,存在于同样含有EF-TuAR的大肠杆菌抗奇霉素突变体(LBE 2012)中。EF-TuAR已从突变菌株LBE 2045中以单一基因产物的形式纯化为均质形式,在该菌株中tuf B基因因噬菌体Mu的插入而失活。EF-TuBO已与EF-TuAR以1:1的混合物形式从LBE 2012中分离出来。用DEAE-葡聚糖A-50对该混合物进行分级分离,使EF-TuBO的富集度约为80%。已将EF-TuAR和EF-TuBO的特性与一种命名为EF-TuAS的奇霉素敏感型进行了比较,EF-TuAS是通过野生型tuf A的转导从LBE 2045中分离出来的。我们在此表明,所有三种EF-Tu都完全能够维持多肽合成。它们似乎也都能与鸟嘌呤核苷酸和EF-Ts正常相互作用。只有在存在抗生素的情况下才会出现以下差异。(a)奇霉素会使EF-TuAS(野生型tuf A基因产物)滞留在核糖体上,从而阻断核糖体。(b)EF-TuAR不能结合抗生素,因此在其存在时能够进行蛋白质合成。(c)EF-TuBO在结合奇霉素后不能维持多肽合成。然而,它不会阻断核糖体,因此同时含有这种蛋白质和EF-TuAR的菌株(LBE 2012)对奇霉素具有抗性。